Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure:
where the definitions of the variables are provided herein.
Rossi,R. et al., Gazzetta Chimica Italiana, 1967, vol. 97, p. 1194 - 1208
作者:Rossi,R. et al.
DOI:——
日期:——
US8778941B2
申请人:——
公开号:US8778941B2
公开(公告)日:2014-07-15
[EN] NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION<br/>[FR] NOUVELLES HÉTEROARYLDIHYDROPYRIMIDINES CONDENSÉES EN POSITION 6 POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION À VIRUS DE L'HÉPATITE B
申请人:HOFFMANN LA ROCHE
公开号:WO2015132276A1
公开(公告)日:2015-09-11
The invention provides novel compounds having the general formula (I): wherein R1, R2, R3, R4, R5, R6, X, Y, W and n are as described herein, compositions including the compounds and methods of using the compounds. These compounds useful for therapy and/or prophylaxis in a human, and in particular to Hepatitis B virus (HBV) inhibitors by targeting on HBV capsid for the treatment of HBV infection.
Preparation of -(3S)-2,3-dimethylpentanal by reaction of (+)-tris[(2S)-1,2-dimethylbutoxy]methane (I) with carbon monoxide and hydrogen
作者:Renzo Rossi、Piero Pino、Franco Piacenti、Luciano Lardicci、Goffredo Del Bino